399 related articles for article (PubMed ID: 23386388)
1. Aggressive locoregional management of recurrent peritoneal sarcomatosis.
Baumgartner JM; Ahrendt SA; Pingpank JF; Holtzman MP; Ramalingam L; Jones HL; Zureikat AH; Zeh HJ; Bartlett DL; Choudry HA
J Surg Oncol; 2013 Mar; 107(4):329-34. PubMed ID: 23386388
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
Baratti D; Pennacchioli E; Kusamura S; Fiore M; Balestra MR; Colombo C; Mingrone E; Gronchi A; Deraco M
Ann Surg Oncol; 2010 Dec; 17(12):3220-8. PubMed ID: 20585874
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis.
Salti GI; Ailabouni L; Undevia S
Ann Surg Oncol; 2012 May; 19(5):1410-5. PubMed ID: 22302269
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent high-grade uterine sarcoma with peritoneal dissemination.
Jimenez WA; Sardi A; Nieroda C; Gushchin V
Am J Obstet Gynecol; 2014 Mar; 210(3):259.e1-8. PubMed ID: 24211479
[TBL] [Abstract][Full Text] [Related]
5. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
[TBL] [Abstract][Full Text] [Related]
6. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
[TBL] [Abstract][Full Text] [Related]
7. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
Lim SJ; Cormier JN; Feig BW; Mansfield PF; Benjamin RS; Griffin JR; Chase JL; Pisters PW; Pollock RE; Hunt KK
Ann Surg Oncol; 2007 Aug; 14(8):2309-18. PubMed ID: 17541691
[TBL] [Abstract][Full Text] [Related]
9. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
Cashin PH; Graf W; Nygren P; Mahteme H
Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
[TBL] [Abstract][Full Text] [Related]
11. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A
Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
[TBL] [Abstract][Full Text] [Related]
12. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
[TBL] [Abstract][Full Text] [Related]
13. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.
Chua TC; Quinn LE; Zhao J; Morris DL
J Surg Oncol; 2013 Aug; 108(2):81-8. PubMed ID: 23737041
[TBL] [Abstract][Full Text] [Related]
14. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Baratti D; Vaira M; Kusamura S; D'Amico S; Balestra MR; Cioppa T; Mingrone E; De Simone M; Deraco M
Eur J Surg Oncol; 2010 Nov; 36(11):1047-53. PubMed ID: 20832234
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis.
Bonvalot S; Cavalcanti A; Le Péchoux C; Terrier P; Vanel D; Blay JY; Le Cesne A; Elias D
Eur J Surg Oncol; 2005 Oct; 31(8):917-23. PubMed ID: 15975759
[TBL] [Abstract][Full Text] [Related]
16. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.
Vaira M; Robella M; Mellano A; Sottile A; De Simone M
Int J Hyperthermia; 2014 Dec; 30(8):565-9. PubMed ID: 25430988
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients.
Rossi CR; Deraco M; De Simone M; Mocellin S; Pilati P; Foletto M; Cavaliere F; Kusamura S; Gronchi A; Lise M
Cancer; 2004 May; 100(9):1943-50. PubMed ID: 15112276
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma.
Tabrizian P; Franssen B; Jibara G; Sweeney R; Sarpel U; Schwartz M; Labow D
J Surg Oncol; 2014 Dec; 110(7):786-90. PubMed ID: 25091997
[TBL] [Abstract][Full Text] [Related]
19. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
[TBL] [Abstract][Full Text] [Related]
20. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
Klaver YL; Chua TC; Verwaal VJ; de Hingh IH; Morris DL
J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
